(MedPage Today) — MINNEAPOLIS — Disappointingly, a growth differentiation factor 15 (GDF-15) neutralizer not only failed to improve functional outcomes in heart failure (HF) but was associated with harm in a trial that was terminated early…
Source link : https://www.medpagetoday.com/meetingcoverage/hfsa/117753
Author :
Publish date : 2025-10-02 16:11:00
Copyright for syndicated content belongs to the linked Source.
